Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141063 |
| CAS No | NA |
| Mol.F. | C16H14N6O8S2 |
| Mol.Wt. | 482.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141064 |
| CAS No | NA |
| Mol.F. | C39H45F2N3O6Si2 |
| Mol.Wt. | 746.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141065 |
| CAS No | NA |
| Mol.F. | C33H29F2N3O6 |
| Mol.Wt. | 601.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141066 |
| CAS No | NA |
| Mol.F. | C18H17FN2O4 |
| Mol.Wt. | 344.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141067 |
| CAS No | NA |
| Mol.F. | C24H22F2N2O4 |
| Mol.Wt. | 440.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141068 |
| CAS No | NA |
| Mol.F. | C35H32FN3O7 |
| Mol.Wt. | 625.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141069 |
| CAS No | NA |
| Mol.F. | C25H21FN2O5 |
| Mol.Wt. | 448.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141070 |
| CAS No | NA |
| Mol.F. | C43H43F2N3O6Si |
| Mol.Wt. | 763.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141071 |
| CAS No | NA |
| Mol.F. | C40H35F2N3O6 |
| Mol.Wt. | 691.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141072 |
| CAS No | NA |
| Mol.F. | C25H21FN2O6 |
| Mol.Wt. | 464.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141073 |
| CAS No | NA |
| Mol.F. | C24H24F2N2O4 |
| Mol.Wt. | 442.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141074 |
| CAS No | NA |
| Mol.F. | C31H30F2N2O4 |
| Mol.Wt. | 532.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141075 |
| CAS No | NA |
| Mol.F. | C24H22F2N2O5 |
| Mol.Wt. | 456.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141076 |
| CAS No | NA |
| Mol.F. | C19H20N4O6 |
| Mol.Wt. | 400.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141077 |
| CAS No | NA |
| Mol.F. | C13H13ClN4O3 |
| Mol.Wt. | 308.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141078 |
| CAS No | NA |
| Mol.F. | C13H15ClN4O |
| Mol.Wt. | 278.7 |
| INV STATUS | CUSTOM SYNTHESIS |